Sanne Venneker

7PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersSolid tumoursAnalytical spectrometryCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME.

|Jul 29, 2023
IDH Mutations in Chondrosarcoma: Case Closed or Not?

Sanne Venneker, Judith V M G Bovée

|Feb 09, 2023
Quantitative multiple fragment monitoring with enhanced in-source fragmentation/annotation mass spectrometry.

Samuel Bernardo-Bermejo, Jingchuan Xue, Linh Hoang

|Feb 02, 2023
Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.

Ieva Palubeckaitė, Sanne Venneker, Brendy E W M van den Akker

|Oct 14, 2022
Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone.

Sanne Venneker, Robin van Eenige, Alwine B Kruisselbrink

|Dec 03, 2020
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma.

Sanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski

Pageof 2

Frequent Collaborators

6 joint publications

Judith V M G Bovée

2 joint publications

Alwine B Kruisselbrink

2 joint publications

Erik H J Danen

2 joint publications

Ieva Palubeckaitė